Answers are grounded in this paper and cite their sources.
The medical management of victims after pulmonary intake of radioactive insoluble particles is a real challenge. The recommended treatment in case of plutonium or cobalt intake is the administration of the chelating agent DTPA, which remains poorly efficient in decreasing lung retention of oxide particles. Bronchoalveolar lavages may be recommended in case of intake expected to cause deleterious consequences, such as lung cancer or fibrosis. However, due to the risk associated to such procedure, bronchoalveolar lavages are not desirable. The inhalation of hypersaline solution is commonly carried out as an alternative to bronchoalveolar lavages in pulmonology for both therapeutic and diagnosis purposes. Based on extensive scientific publications reporting the effect of sputum induction by inhalation of hypertonic saline solution, we envision a new alternative for the treatment of pulmonary intake with poorly soluble radioactive particles by enhancing mucociliary clearance and thus accelerating the removal of deposited particles. In addition, the analysis of sputum samples obtained by hypersaline aerosol inhalation should bring valuable information regarding the properties of the inhaled radioactive compounds as well as the level of exposure intake. After a brief review of the literature, the present work will discuss which parameters influence the quality and the origin of the samples after sputum induction and will propose recommendations to apply this procedure as a first-line treatment and diagnosis after pulmonary of radioactive poorly soluble particles.
No takes yet. Share an insight, caveat, or question.
Peiffer et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: